C4 Therapeutics (CCCC) EBITDA Margin Growth (1y) (2020 - 2026)
C4 Therapeutics (CCCC) EBITDA Margin Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,552.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,536.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -170.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1,049.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | C4 Therapeutics | 460.17 Mn | 224.50 Mn | - | -4,871.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4,871.00 |
| Dec 31, 2025 | 51,829.00 |
| Sep 30, 2025 | -12,257.00 |
| Jun 30, 2025 | -26,239.00 |
| Mar 31, 2025 | 65,726.00 |
| Dec 31, 2024 | 41,932.00 |
| Sep 30, 2024 | 6,730.00 |
| Jun 30, 2024 | 123,162.00 |
| Mar 31, 2024 | -9,642.00 |
| Dec 31, 2023 | 19,402.00 |
| Sep 30, 2023 | 22,986.00 |
| Jun 30, 2023 | -121,226.00 |
| Mar 31, 2023 | -55,393.00 |
| Dec 31, 2022 | -126,575.00 |
| Sep 30, 2022 | -19,568.00 |
| Jun 30, 2022 | 2,816.00 |
| Mar 31, 2022 | -13,366.00 |
| Dec 31, 2021 | 15,282.00 |
| Sep 30, 2021 | -6,812.00 |
| Jun 30, 2021 | -11,382.00 |